{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T20:24:18Z","timestamp":1791750258737,"version":"4.3.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.ejso.2005.05.009","type":"journal-article","created":{"date-parts":[[2005,7,12]],"date-time":"2005-07-12T20:13:10Z","timestamp":1121199190000},"page":"1006-1010","source":"Crossref","is-referenced-by-count":40,"title":["A multicenter study of CA 125 level as a predictor of non-optimal primary cytoreduction of advanced epithelial ovarian cancer"],"prefix":"10.1016","volume":"31","author":[{"given":"O.","family":"Gemer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lurian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gdalevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Kapustian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Piura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Lavie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Fishman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Dgani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Levavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Beller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2005.05.009_bib1","first-page":"413","article-title":"Primary cytoreductive surgery for epithelial ovarian cancer","volume":"61","author":"Hacker","year":"1983","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejso.2005.05.009_bib2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0090-8258(92)90100-W","article-title":"The influence of cytoreductive surgery on recurrence-free interval and survival in small volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study","volume":"47","author":"Hoskins","year":"1992","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2005.05.009_bib3","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0002-9378(94)70090-7","article-title":"The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma","volume":"170","author":"Hoskins","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejso.2005.05.009_bib4","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2005.05.009_bib5","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s11912-003-0008-8","article-title":"The role of interval debulking surgery in ovarian cancer","volume":"5","author":"Van Der Burg","year":"2003","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.ejso.2005.05.009_bib6","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJM199503093321002","article-title":"The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gyncological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer","volume":"332","author":"Van der Burg","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejso.2005.05.009_bib7","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1006\/gyno.1998.5213","article-title":"Neoadjuvant chemotherapy of primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients","volume":"71","author":"Vergote","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2005.05.009_bib8","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1200\/JCO.1993.11.1.166","article-title":"Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma","volume":"11","author":"Nelson","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2005.05.009_bib9","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2214\/ajr.165.4.7676985","article-title":"Ovarian carcinoma: value of CT in predicting success of debulking surgery","volume":"165","author":"Meyer","year":"1995","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ejso.2005.05.009_bib10","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/1097-0142(20001001)89:7<1532::AID-CNCR17>3.0.CO;2-A","article-title":"A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography","volume":"89","author":"Bristow","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2005.05.009_bib11","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/cncr.20376","article-title":"The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma","volume":"101","author":"Dowdy","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2005.05.009_bib12","first-page":"140","article-title":"Relationship of preoperative serum CA-125 to epithelial ovarian carcinoma","volume":"41","author":"Geisler","year":"1996","journal-title":"J Reprod Med"},{"key":"10.1016\/j.ejso.2005.05.009_bib13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1006\/gyno.2000.5749","article-title":"The ability of preoperative serum CA-125 to predict optimal primary tumour cytoreduction in stage III epithelial ovarian carcinoma","volume":"77","author":"Chi","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2005.05.009_bib14","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/j.1600-0412.2001.080006583.x","article-title":"Preoperative CA-125 level as a predictor of non optimal cytoreduction of advanced epithelial ovarian cancer","volume":"80","author":"Gemer","year":"2001","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ejso.2005.05.009_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0029-7844(02)02057-4","article-title":"Preopetrative CA 125 levels: an independent prognostic factor for epithelial ovarian cancer","volume":"100","author":"Cooper","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejso.2005.05.009_bib16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1006\/gyno.2002.6719","article-title":"Can serum CA-125 levels predict the optimal primary cytoreduction in patients with advanced ovarian carcinoma?","volume":"86","author":"Saygili","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2005.05.009_bib17","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.1525-1438.2003.13019.x","article-title":"CA125 levels are a weak predictor of optimal cytoreductive surgery in patients with advanced epithelial ovarian cancer","volume":"13","author":"Memarzadeh","year":"2003","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejso.2005.05.009_bib18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1048-891x.2004.14065.x","article-title":"Preoperative predictors of suboptimal primary surgical cytoreduction in women with clinical evidence of advanced primary epithelial ovarian cancer","volume":"14","author":"Brockbank","year":"2004","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejso.2005.05.009_bib19","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijgo.2003.10.006","article-title":"C-125 levels in predicting optimal cytoreductive surgery in patients with advanced epithelial ovarian carcinoma","volume":"84","author":"Alc\u00e1zer","year":"2004","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.ejso.2005.05.009_bib20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000076236","article-title":"Can optimal primary cytoreduction be predicted in advanced stage epithelial ovarian cancer? Role of preoperative serum CA-125 level","volume":"57","author":"Obeidat","year":"2004","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.ejso.2005.05.009_bib21","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.ajog.2004.02.005","article-title":"Prediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarrays","volume":"190","author":"Berchuck","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejso.2005.05.009_bib22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/gyno.1998.4955","article-title":"Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study","volume":"69","author":"Eisenkop","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2005.05.009_bib23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/gyno.1998.5236","article-title":"Neoadjuvant chemotherapy for advanced ovarian cancer: long-term survival","volume":"72","author":"Schwartz","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2005.05.009_bib24","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1002\/1097-0142(20010615)91:12<2329::AID-CNCR1265>3.0.CO;2-U","article-title":"Neoadjuvant chemotherapy for unresectable ovarian carcinoma: a French multicenter study","volume":"91","author":"Ansquer","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2005.05.009_bib25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1006\/gyno.2000.5808","article-title":"Preoperative prediction of optimal resectability in advanced ovarian cancer using CA-125","volume":"77","author":"Berek","year":"2000","journal-title":"Gynecol Oncol"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798305001538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798305001538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T04:48:52Z","timestamp":1551847732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798305001538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0748798305001538"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2005.05.009","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}